Abstract -Zerumbone (ZER) is derived from Zingiber zerumbet smith from the Zingiberaceae family. It has been shown to have anti-cancer and apoptosis-inducing properties against various human tumour cells. The aim of our study was to assess the genotoxic effects of ZER in cultured human peripheral blood lymphocytes, Chinese Hamster Ovary (CHO) cells and rat bone marrow polychromatic erythrocytes (PCEs) using micronucleus test (MN). All in vitro treatments were carried out in the absence of any exogenous metabolic activation system. Mitomycin C (MMC) was used as a positive control for in vitro treatments, while cisplatin was used as a positive micronucleus inducer in rat bone marrow PCEs. ZER at high concentrations induced an apparent signifi cant increase in the frequency of micronuclei in vivo (1000 mg/kg b.w) and in vitro (40 and 80 µM) compared to concurrent control values. Our in vivo and in vitro cytogenotoxicity studies suggest that high doses of ZER may be genotoxic and cytotoxic.
INTRODUCTION
Zingiber zerumbet smith is used in local traditional medicine as a cure for a number of illnesses, locally known as 'lempoyang' wild ginger belongs to Zingiberaceae family. It is native to South East Asia but has been widely cultivated plant in village gardens throughout the tropical and subtropical area around the world and has naturalized in some areas for its medicinal properties. In some Southeast Asian countries, the rhizomes of the plant are employed as traditional medicines for anti-infl ammation, while the young shoots and infl orescence are used as condiments. Scientifi c research towards Zingiber zerumbet proved that it contained a suppressive effect which was conducted by a bioactive compound, zerumbone. It has been shown that zerumbone is one of the most promising chemopreventive agents against colon and skin cancer (MURAKAMI et al. 2004) . It was reported to suppress colonic tumour marker formation in rats and potentiated TRAIL-induced apoptosis in human HCT116 colon cancer cells (YODKEEREE et al. 2009) . The compound was shown to inhibit the proliferation of human colonic adenocarcinoma cell lines in a dose-dependent manner, while the growth of normal human dermal and colon fi broblast was less affected (MURAKAMI et al. 2004) . Zerumbone was further demonstrated to inhibit both azoxymethane-induced rat aberrant crypt foci and phorbol ester-induced papilloma formation in mouse skin a further indication of its effi cacy to prevent colon and skin cancers (MURAKAMI et al. 2004; TANAKA et al. 2001) . Recently, Sung et al., (2009) reported zerumbone as modulator for osteoclastogenesis induced by RANKL and breast cancer (SUNG et al. 2009 ).
Genotoxicity studies of both naturally occurring and synthetic substances are of great interest because of the widespread and often chronic use of herbal remedies, of modern medicinal products, of food ingredients, as well as of other household and environmental chemicals. Many plant products contain compounds known to cause various diseases or even death in animals and humans (DEARFIELD et al. 2002; AMES and GOLD 1997; RASKIN et al 2002; RATES 2001) . Synthetic substances present as environmental pollutants, and toxicants may cause similar effects (AMES and GOLD 1997; RATES 2001) . Many natural and synthetic compounds have been reported to act as mutagens and/or carcinogens (VARGAS et al. 1990) .
A variety of in vitro genotoxicity test systems have been developed including the cultured mammalian cell systems such as human peripheral blood lymphocytes cells (PBL) or Chinese hamster ovary (CHO) cells (DEAN and DAN-FORD 1984; SCOTT et al. 1990) , for the screening of potentially mutagenic, carcinogenic and/or teratogenic agents. The CBMN assay in human lymphocytes uses cytochalasin-B, an inhibitor of actins polymerisation, which prevents cytokinesis while permitting nuclear division (FENECH and MORLEY 1985) . As a result, binucleated (BN) cells are produced, which are scored for the presence of MN (FENECH 1993) . The rodent bone-marrow MN test is the most widely used short-term in vivo assay for the identifi cation of genotoxic effects such as chromosome damage and aneuploidy associated with mutagenesis and carcinogenesis (VANDERKERKEN et al 1989) .
Taking into account the lack of information about in vivo and in vitro cytogenetic effects of zerumbone, we decided to provide some data on the cytogenetic activity of this compound. Here we report the results obtained on the cytogenetic effects of zerumbone in vivo using rat bone marrow erythrocyte micronucleus (MNPCE), in vitro chromosomal aberrations assay and micronucleus test using human lymphocytes (PBL) and micronucleus test in cultured CHO cell.
MATERIALS AND METHODS
Zerumbone extraction -Zerumbone was extracted in the laboratory of cancer research MAK-NA-UPM, University Putra Malaysia, from the rhizomes of Zingiber zerumbet plant. The rhizomes obtained from the wet market in Kuala Lumpur, Malaysia. Zerumbone was extracted, isolated and purifi ed using methanol extraction and column chromatography (CC) method. The isolated and purifi ed zerumbone crystals were subjected to High Performance Liquid Chromatography (HPLC) and Liquid Chromatography Mass Spectrometry (LCMS) to confi rm its purity and molecular weight. Further, 13 C NMR and 1 H NMR analysis were conducted towards the zerumbone crystals to confi rm its molecular structure (Figure 1) The rats were maintained in group per cage at room temperature (25±1 C) and 12-h light: 12-h dark cycle and were given food and water ad libitum. The animals were acclimatised for at least 5 days prior to dosing and were divided into fi ve groups containing 3-6 rats each. Three dose levels of zerumbone (250, 500, 1000 mg/kg) were given intraperitoneal for 24h. Dose selection was based on preliminary experiments in which the maximum tolerable dose (MTD) was identifi ed to be 1000 mg/kg body weight. An untreated control and a positive control (cisplatin 10 mg/ kg) were also used to test the validity of the assay. The experiment complied with the guide for Animal Care and Use Committee (ACUC), Faculty of Medicine and Health Sciences, University Putra Malaysia.
After 24h the animals were anesthetized with chloroform and sacrifi ced. For bone-marrow preparations, both hind femora were isolated and the adherent muscle removed. The epiphyses were cut off and bone marrow cells were fl ushed out with foetal bovine serum (PAA Laboratories). The suspension of bone marrow cells and foetal bovine serum was centrifuged for 10 min at 1000 rpm. The resulting sediment was re-suspended in foetal bovine serum. Bone marrow smears were prepared from the resulting cell suspension. After air-drying and fi xing for 10 min in absolute methanol, slides were stained with Giemsa-staining method. The slides were analyzed in a blinded fashion using a Nikon light microscope. Both normochromatic erythrocytes (NCE) and polychromatic erythrocytes (PCE) were scored for bone marrow activity and PCEs were scored for micronuclei (MN). A total of 2000 polychromatic erythrocytes were scored per animal for MNPCE and 200 erythrocytes were counted for the PCE: NCE ratio according to the OECD guideline for testing of chemicals (mammalian erythrocyte micronucleus test), guideline No. 474 (OECD 1997) . For every group of animals, the following parameters were reported, the number of MN-containing cells/2000 PCE/animal, the number of PCE; the number of NCE and the NCE: PCE ratio. Micronucleus test in cultured human lymphocytes -Buffy coat (0.2 ml) was added to 5ml RPMI-1640 medium supplemented with 20% heat inactivated foetal bovine serum, antibiotics (penicillin and streptomycin) and L-glutamine (PAA laboratories). Lymphocytes were stimulated by adding 2% phytohaemagglutinin (PHA) (Gibco). The cultured lymphocytes were incubated for 48h before treatment with zerumbone. The cultures were incubated at 37°C for 72h and treated with zerumbone at 5, 10, 20, 40 and 80µM during the last 24h. A control untreated culture, MMC treated and ethanol treated cultures were established as well. Cytochalasin-B (6µg/ml) was added to arrest cytokinesis at 44h after the start of the culture. Then, the cells were harvested by centrifugation (1000rpm, 10min), and the pellet was re-suspended in a pre-warmed hypotonic solution of 0.075M KCI for 5 min. Cells were re-centrifuged and fi xed three times in cold methanol: acetic acid (3:1). Slides were prepared by dropping and air-drying. Finally slides were stained with 5% Giemsa (pH 6.8) in phosphate buffer for 10 min, washed in distilled water, dried at room temperature and mounted. Scoring -The induction of MN was determined in 1000 binucleated cells with the cytoplasm well preserved. In a blind test, using a Nikon microscope, cells containing 1 micronuclei were scored. The criterion for the identifi cation of MN was according to Fenech (FENECH 1993) . In each treatment, the numbers of mononucleated, binucleated, and polynucleated cells per 500 cells were counted for cell cycle kinetic analysis and cytochalasin B proliferation index (CBPI) as determined in a blind test. Cells with well preserved cytoplasm, containing 1-4 nuclei, were where MI-MIV correspond to the numbers of cells with one, two, three and four nuclei and N is the total number of cells (SURALLES et al. 1995) .
Micronucleus test (MN)
in CHO -Chinese hamster ovary (CHO) cells were purchased from ECACC (UK). The cells grow as an adherent monolayer in appropriate tissue culture vessels and were maintained in RPMI 1640 medium (PAA Laboratories, Germany) supplemented with 10% foetal bovine serum (PAA Laboratories, Germany). The cells were incubated in a humidifi ed tissue culture incubator at 37°C and 5% CO 2 . The overnight cell cultures were examined under an inverted microscope. Duplicate cultures were prepared for each test substance concentration and controls. Control cultures were handled in a manner identical to the treated ones. Mitomycin-C (Sigma) was used as a positive control. The treatment medium was 5 ml of the cell culture medium with 10% foetal bovine serum, with the treatment concentration or a control solution and the fi nal concentrations were 5, 10, 20, 40 and 80µM ZER. The cells were cultured in the treatment medium for 48h. After treatment, cells were washed twice with 10 mL PBS, trypsinized with 0.05% trypsin and centrifuged for 5 min at 800 rpm. CHO cells were then harvested and scored using the same method of human lymphocytes micronucleus mentioned above. Statistical analysis -Statistical analysis was performed using SPSS 15. Rat bone marrow erythrocytes MN results were expressed as mean ± SE and were analyzed with one way analysis of variance, ANOVA, while the results from in vitro work were analyzed using Chi square analysis. All statistical tests were performed at the p<0.05 level of signifi cance.
RESULTS
Cytotoxicity analysis -Cytotoxicity assay must be performed fi rst on the chemicals that are not known to cause any chromosome aberrations for the evidence of cytotoxicity in the system chosen for genotoxicity testing (SCOTT et al. 1990 ). This would help the establishment of a maximum tolerated dose (MTD) of the chemical being tested. In our study, the MTT cytotoxicity assay was employed in determining the dose response of ZER. CHO cells as well as different cancer cell lines, including Hela, MCF7 and MDA-MB 231 cell lines, were used to determine the IC 50 of ZER. The IC 50 value obtained was showed to be around 20.0 (± 5.1) µM. Rat bone marrow MNPCE -Micronucleus frequencies observed in polychromatic erythrocytes as well as the ratio of polychromatic to normochromatic erythrocytes of male rats are shown in Table 1 . The acute exposure to ZER resulted in signifi cant increase in the number of micronuclei in polychromatic erythrocytes (MNPCEs) of the group exposed to the highest drug concentration compared with the control group (0.76±0.16/100 PCEs against 0.15±0.04/100 PCEs; P < 0.05), Table 2 . Tables 2 and 3 show the results obtained for the MN frequencies and CBPI after treatments of CHO cell lines for 48h and human peripheral blood lymphocyte for 24h, 
In vitro MN induction -

DISCUSSION
Antitumor agents are known to interact with specifi c biological molecules, and evidence has been obtained that treatment with antitumor drugs from different categories leads to generation of free radicals in nontumor cells both in vivo and in vitro (WEIJL et al. 1997) . Zerumbone a natural compound extracted from Z. zerumbet, has been found able to exert antitumor activity (KOSHIMIZU et al. 1998) , anti-infl ammatory effects and possesses anti-proliferative potentials in a variety of cancer cell lines (MURAKAMI et al. 2002) . Moreover, zerumbone was reported to act as a cytoselective anticancer agent (MURAKAMI et al. 2002) . In cancer chemotherapy, genotoxicity effects should be determined before or during the phase I clinical trials (PRATT et al. 1994) . Since the cytogenetic effects of zerumbone in vivo and in vitro have not yet been attempted and due to the lack of information available on the cytogenotoxicity of ZER; this study aims to investigate the effects of zerumbone that could be exerted on chromosomes in vivo and in vitro using micronucleus test.
As part of its preclinical safety assessment program, ZER was assessed for genotoxic potential by means of a micronucleus test in cultured human lymphocytes and CHO cells as well as in vivo rat bone marrow polychromatic erythrocyte micronucleus (PCEMN) test. Besides the possible use of ZER as a therapeutic agent, knowledge about its genotoxic potential is also of interest from the point of view of human ZER-containing food consumption. The use of in vivo and in vitro assays was decisive in order to obtain a picture of the genotoxic potential of this plant product.
The cytotoxicity indices employed in this study showed that ZER has an antiproliferative activity in vitro against different cell types. However, the inhibitory effect of ZER was observed to be signifi cantly different (P < 0.05) compared to the untreated control after treatment with the highest drug concentration (80 µM). This effect was confi rmed by the results of CBPI in which high drug concentrations found to inhibit the proliferation of human lymphocytes signifi cantly.
Genotoxic agents have the potential to interact with DNA and may cause DNA damage. Chromosomal aberration occurs in proliferating cells is regarded as a manifestation of damage to the genome. It has been commonly used as a test of mutagencity in order to evaluate cytogenetic responses to chemical exposure. With respect to the cytogenetic parameters studied in human lymphocytes, our results reveal that 20 µM does not cause signifi cant changes. Whereas, increasing concentrations of (40 and 80 µM) consider- The numbers of mononucleated (M1), binucleated (M2), and polynucleated (M3) cell per 500 cells were quantitated for cell cycle kinetic analysis. *P < 0.05, signifi cantly different from control.
ably elevated the frequencies of MN formations compared to the concurrent controls, both in human lymphocyte when treated for 24h as well as in CHO cells when treated for 48h. The percentage of structurally damaged cells in the MMC (positive control) treatment groups was statistically increased compared to the solvent control data indicating the responsiveness of the cells in this test system. Analysis of the frequency of occurrence of micronuclei in treated cells provides a comparatively rapid and sensitive indication of both chromosomal aberrations and chromosome loss that lead to numerical chromosomal anomalies. Micronuclei are cytoplasmic chromatin masses with the appearance of small nuclei that arise from chromosome lagging at anaphase or from acentric chromosomal fragments. They provide a quantifi able measure of recent DNA injury that result from when acentric fragments or whole chromosomes are left behind the main nucleus at telophase. An increase in the prevalence of MN in a population of cells indicates that chromosome damage has occurred as a result of an exposure that caused either clastogenic or an aneuploidogenic effect (GONSEBATT et al. 1997; MAHATA et al. 2003) . MN assay is a widely used cytogenetic method to assess in vivo and in vitro chromosomal damage. However, the MN study is the most reproducible one to show positive effects (ROBBIANO et al. 1998) . Results of MN induction in human lymphocytes revealed the ability of this compound at high dose to act as aneugenic/clastogenic substance by inducing MN formation in human lymphocytes in vitro.
The lethal dose (LD) of 2000 mg/kg b.w. was determined in rat after intraperitoneal administration of ZER. In the present experimental conditions, a signifi cant increase in rat bone marrow micronuclei was recorded at the highest dose (1000 mg/kg b.w.). The induction of micronucleated erythrocytes following exposure to high dose of ZER indicates a potential for clastogenicity. In the present study, the observed inhibition of cell proliferation in the rat bone marrow illustrates the cytotoxicity of ZER. These data indicate the cytotoxic potential of ZER at higher exposure doses.
Our results show that the increase in MN, and the decrease in the PCE:NCE ratio was dose-dependent. We found that there is a linear relationship between the ZER dose used and the frequencies of micronuclei. It is concluded that ZER has a cytotoxic effect on bone marrow in rats, because the decrease in the ratio PCE:NCE was observed at all doses compared with the control. Such a decreased ratio is often used as an indicator of bone marrow cytotoxicity or alterations in erythropoiesis. In normal bone marrow, the PCE:NCE ratio is generally around 1:1.
In conclusion our in vivo and in vitro cytogenotoxicity studies suggest that high doses of zerumbone used in the present investigation may be genotoxic and cytotoxic. It is important to carry out more investigations using various cytogenetic tests under different experimental conditions to assess more the genotoxic effects of zerumbone.
